Release date: 2024-08-23 17:55:48 Article From: Lucius Laos Recommended: 179
Patients with HR/HER2- advanced breast cancer harboring PIK3CA mutations were significantly delayed in disease progression under the combination of Alpelisib and fulvestrant.
The dosing and dosing recommendations for apellix should be adjusted on an individual basis and should be determined by the physician.
The standard dose of Alpelisib is 300 mg once daily with two 150 mg film-coated tablets. It is recommended to take it with a meal to improve the absorption of the drug.
If you miss a dose of apelix, you can take that dose with a meal within 9 hours of the usual time of taking the dose. If it is more than 9 hours, skip the dose for the day and take it at the normal time the next day.
The Dosage and Dosage Instructions for Alpelisib provide general advice. Patients should discuss with their doctor how to adjust the use of the method according to their individual situation. Medication modification for special populations is also important when using Apelix.
In certain populations, the regimen of apellix may need to be specifically modified.
In the trial, patients over 65 years of age had a higher incidence of hyperglycaemia, but there was no significant difference in efficacy. There are insufficient data in patients over 75 years of age to fully assess efficacy.
The effect of severe renal impairment on Alpelisib is unclear. Patients with mild to moderate renal impairment do not need to adjust the dose.
Medication modification in special populations is essential for successful treatment. Below we will describe the possible adverse effects when using Apelix.
There may be some side effects associated with the use of Apelix, and the following are the common adverse reactions.
Drugs can trigger abnormal liver function, leading to an increase in GGT levels. Liver function needs to be monitored to avoid potential liver damage.
Drugs can cause liver cell damage, which manifests as elevated levels of ALT. Liver function tests need to be done regularly to avoid serious liver problems.
Understanding these adverse effects can help identify and address problems in a timely manner during treatment and better manage the treatment process.
[Warm tips] Regular check-ups, maintain communication with doctors, and pay attention to physical changes. If you have any discomfort or doubts, consult your doctor promptly.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: